 |
 |
 |
 |
 |
|
biochemical hepatologySelected PublicationsCASTILLO J, GOÑI S, LATASA MU, PERUGORRÍA MJ, CALVO A, MUNTANÉ J, BIOULAC-SAGE P, BALABAUD C, PRIETO J, AVILA MA, BERASAIN C. Amphiregulin Induces the Alternative Splicing of p73 Into Its Oncogenic Isoform DeltaEx2p73 in Human Hepatocellular Tumors. Gastroenterology. 2009 Aug 5. BERASAIN C, PERUGORRIA MJ, LATASA MU, CASTILLO J, GOÑI S, SANTAMARÍA M, PRIETO J, AVILA MA. The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med (Maywood). 2009 Jul;234(7):713-25. Epub 2009 May 8. PERUGORRIA MJ, CASTILLO J, LATASA MU, GOÑI S, SEGURA V, SANGRO B, PRIETO J, AVILA MA, BERASAIN C. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy. Cancer Res. 2009 Feb 15;69(4):1358-67. Epub 2009 Feb 3.
ABSTRACT COURTESY OF PUBMEDBERASAIN C, CASTILLO J, PERUGORRIA MJ, LATASA MU, PRIETO J, AVILA MA. Inflammation and liver cancer: new molecular links. Ann NY Acad Sci. 2009;1155:206-21.
ABSTRACT COURTESY OF PUBMEDPERUGORRIA MJ, LATASA MU, NICOU A, CARTAGENA-LIROLA H, CASTILLO J, GOÑI S, VESPASIANI-GENTILUCCI U, ZAGAMI MG, LOTERSZTAJN S, PRIETO J, BERASAIN C, AVILA MA. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. Hepatology. 2008 Oct;48(4):1251-61.
ABSTRACT COURTESY OF PUBMEDFERNÁNDEZ-IRIGOYEN J, SANTAMARÍA M, SÁNCHEZ-QUILES V, LATASA MU, SANTAMARÍA E, MUÑOZ J, SÁNCHEZ DEL PINO MM, VALERO ML, PRIETO J, AVILA MA, CORRALES FJ. Redox regulation of methylthioadenosine phosphorylase in liver cells: molecular mechanism and functional implications. Biochem J. 2008 Apr 15;411(2):457-65.
ABSTRACT COURTESY OF PUBMEDIÑIGUEZ M, DOTOR J, FEIJOO E, GOÑI S, PRIETO J, BERASAIN C, AVILA MA. Novel pharmacologic strategies to protect the liver from ischemia-reperfusion injury. Recent Pat Cardiovasc Drug Discov. 2008 Jan;3(1):9-18. Review.
ABSTRACT COURTESY OF PUBMEDBERASAIN C, CASTILLO J, PRIETO J, AVILA MA. New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system. ABSTRACT COURTESY OF PUBMEDLiver Int. 2007 Mar;27(2):174-85. BERASAIN C, CASTILLO J, PERUGORRIA MJ, PRIETO J, AVILA MA. Amphiregulin: A new growth factor in hepatocarcinogenesis. Cancer Lett. 2007;254(1):30-41. ABSTRACT COURTESY OF PUBMEDIÑIGUEZ M, BERASAIN C, MARTÍNEZ-ANSÓ E, BUSTOS M, FORTES P, PENNICA D, AVILA MA, PRIETO J. Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning. ABSTRACT COURTESY OF PUBMEDJ Exp Med. 2006;203(13):2809-15. AVILA MA, BERASAIN C, SANGRO B, PRIETO J. New therapies for hepatocellular carcinoma. Oncogene 2006;25(27):3866-84. ABSTRACT COURTESY OF PUBMED |
|
|